FDA-Approved Study to Investigate Therapeutic Potential of Mushroom-Derived Psilocin and Psilocybin
Thu / Jul 7th
Filament Health has begun its Phase 1 study investigating naturally-derived psilocin and psilocybin, the first such study ever approved by the FDA.